Balloon Dilation With Adequate Duration Is Safer Than Sphincterotomy for Extracting Bile Duct Stones: A Systematic Review and Meta-analyses

Clinical Gastroenterology and Hepatology

Volumn 10, Issue 10, 2012, Pages 1101-1109

  Liao, Wei Chih ^a,b   Tu, Yu Kang ^b,c   Wu, Ming Shiang ^a   Wang, Hsiu Po ^a   Lin, Jaw Town ^a,d   Leung, Joseph W ^e   Chien, Kuo Liong ^a,b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c LEEDS DENTAL INSTITUTE   (United Kingdom)

^d E DA HOSPITAL   (Taiwan)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Gallbladder; Mixed Treatment Comparison; Risk Factor; Sphincteroplasty

Indexed keywords

ARTICLE; BALLOON DILATATION; BILE DUCT STONE; CHOLANGITIS; COMMON BILE DUCT STONE; COMPARATIVE EFFECTIVENESS; ENDOSCOPIC PAPILLARY BALLOON DILATION; ENDOSCOPIC SPHINCTEROTOMY; ENDOSCOPIC THERAPY; HUMAN; META ANALYSIS; OPERATION DURATION; OUTCOME ASSESSMENT; PANCREATITIS; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; RECURRENT DISEASE; SYSTEMATIC REVIEW; THROMBOEMBOLISM;

ENDOSCOPY, GASTROINTESTINAL; GALLSTONES; HUMANS; PANCREATITIS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; TIME FACTORS;

EID: 84866464267     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2012.05.017     Document Type: Article

References (48)

1. Baron T.H., Harewood G.C. Endoscopic balloon dilation of the biliary sphincter compared to endoscopic biliary sphincterotomy for removal of common bile duct stones during ERCP: a metaanalysis of randomized, controlled trials. Am J Gastroenterol 2004, 99:1455-1460.
2. Disario J.A., Freeman M.L., Bjorkman D.J., et al. Endoscopic balloon dilation compared with sphincterotomy for extraction of bile duct stones. Gastroenterology 2004, 127:1291-1299.
3. Vlavianos P., Chopra K., Mandalia S., et al. Endoscopic balloon dilatation versus endoscopic sphincterotomy for the removal of bile duct stones: a prospective randomised trial. Gut 2003, 52:1165-1169.
4. Bergman J.J., van Berkel A.M., Groen A.K., et al. Biliary manometry, bacterial characteristics, bile composition, and histologic changes fifteen to seventeen years after endoscopic sphincterotomy. Gastrointest Endosc 1997, 45:400-405.
5. Minami A., Nakatsu T., Uchida N., et al. Papillary dilation vs sphincterotomy in endoscopic removal of bile duct stones: a randomized trial with manometric function. Dig Dis Sci 1995, 40:2550-2554.
6. Bergman J.J., Rauws E.A., Fockens P., et al. Randomised trial of endoscopic balloon dilation versus endoscopic sphincterotomy for removal of bile duct stones. Lancet 1997, 349:1124-1129.
7. Fujita N., Maguchi H., Komatsu Y., et al. Endoscopic sphincterotomy and endoscopic papillary balloon dilatation for bile duct stones: a prospective randomized controlled multicenter trial. Gastrointest Endosc 2003, 57:151-155.
8. Komatsu Y., Kawabe T., Toda N., et al. Endoscopic papillary balloon dilation for the management of common bile duct stones: experience of 226 cases. Endoscopy 1998, 30:12-17.
9. Lin C.K., Lai K.H., Chan H.H., et al. Endoscopic balloon dilatation is a safe method in the management of common bile duct stones. Dig Liver Dis 2004, 36:68-72.
10. Sato H., Kodama T., Takaaki J., et al. Endoscopic papillary balloon dilatation may preserve sphincter of Oddi function after common bile duct stone management: evaluation from the viewpoint of endoscopic manometry. Gut 1997, 41:541-544.
11. Weinberg B.M., Shindy W., Lo S. Endoscopic balloon sphincter dilation (sphincteroplasty) versus sphincterotomy for common bile duct stones. Cochrane Database Syst Rev 2006, 4. CD004890.
12. Attam R., Freeman M.L. Endoscopic papillary balloon dilation for stone extraction: if, when, and for how long?. Gastrointest Endosc 2010, 72:1163-1166.
13. Liao W.C., Lee C.T., Chang C.Y., et al. Randomized trial of 1-minute versus 5-minute endoscopic balloon dilation for extraction of bile duct stones. Gastrointest Endosc 2010, 72:1154-1162.
14. Fletcher J. What is heterogeneity and is it important?. BMJ 2007, 334:94-96.
15. Moher D., Liberati A., Tetzlaff J., et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009, 151:264-269. W64.
16. Attam R., Freeman M.L. Endoscopic papillary large balloon dilation for large common bile duct stones. J Hepatobiliary Pancreat Surg 2009, 16:618-623.
17. Attasaranya S., Cheon Y.K., Vittal H., et al. Large-diameter biliary orifice balloon dilation to aid in endoscopic bile duct stone removal: a multicenter series. Gastrointest Endosc 2008, 67:1046-1052.
18. Cotton P.B., Lehman G., Vennes J., et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991, 37:383-393.
19. Higgins J.P., Altman D.G. Assessing risk of bias in included studies. Cochrane handbook for systematic reviews of interventions 2011, 607-631. John Wiley & Sons, Chichester, UK. J.P. Higgins, S. Green (Eds.).
20. Higgins J.P., Thompson S.G., Deeks J.J., et al. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
21. Thompson S.G., Sharp S.J. Explaining heterogeneity in meta-analysis: a comparison of methods. Stat Med 1999, 18:2693-2708.
22. Egger M., Davey Smith G., Schneider M., et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
23. Sweeting M.J., Sutton A.J., Lambert P.C. What to add to nothing?. use and avoidance of continuity corrections in meta-analysis of sparse data. Stat Med 2004, 23:1351-1375.
24. Sutton A.J., Abrams K.R. Bayesian methods in meta-analysis and evidence synthesis. Stat Methods Med Res 2001, 10:277-303.
25. Ades A.E., Sculpher M., Sutton A., et al. Bayesian methods for evidence synthesis in cost-effectiveness analysis. Pharmacoeconomics 2006, 24:1-19.
26. Song F., Altman D.G., Glenny A.M., et al. Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses. BMJ 2003, 326:472.
27. Sutton A., Ades A.E., Cooper N., et al. Use of indirect and mixed treatment comparisons for technology assessment. Pharmacoeconomics 2008, 26:753-767.
28. Brooks S.P., Gelman A. General methods for monitoring convergence of iterative simulations. J Comput Graph Stat 1998, 7:434-455.
29. Yasuda I., Fujita N., Maguchi H., et al. Long-term outcomes after endoscopic sphincterotomy versus endoscopic papillary balloon dilation for bile duct stones. Gastrointest Endosc 2010, 72:1185-1191.
30. de los Campo Fernandez de los Rios R., Brullet Benedí E. Endoscopic treatment of choledocholithiasis in patients with Billroth II gastrectomy by dilatation with papillary balloon. Gastroenterol Hepatol 1998, 21:391-393.
31. Liao W.C., Huang S.P., Wu M.S., et al. Comparison of endoscopic papillary balloon dilatation and sphincterotomy for lithotripsy in difficult sphincterotomy. J Clin Gastroenterol 2008, 42:295-299.
32. Mac Mathuna P., Siegenberg D., Gibbons D., et al. The acute and long-term effect of balloon sphincteroplasty on papillary structure in pigs. Gastrointest Endosc 1996, 44:650-655.
33. Elta G.H., Elmunzer B.J. Biliary tract motor function and dysfunction. Sleisenger & Fordtran's gastrointestinal and liver disease 2010, 1067-1076. W. B. Saunders, Philadelphia. 9th ed. M. Feldman, L.S. Friedman, L.J. Brandt (Eds.).
34. Ersoz G., Tekesin O., Ozutemiz A.O., et al. Biliary sphincterotomy plus dilation with a large balloon for bile duct stones that are difficult to extract. Gastrointest Endosc 2003, 57:156-159.
35. Jeong S., Ki S.H., Lee D.H., et al. Endoscopic large-balloon sphincteroplasty without preceding sphincterotomy for the removal of large bile duct stones: a preliminary study. Gastrointest Endosc 2009, 70:915-922.
36. Hardy R.J., Thompson S.G. Detecting and describing heterogeneity in meta-analysis. Stat Med 1998, 17:841-856.
37. Freeman M.L., Nelson D.B., Sherman S., et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996, 335:909-918.
38. Anderson M.A., Ben-Menachem T., Gan S.I., et al. Management of antithrombotic agents for endoscopic procedures. Gastrointest Endosc 2009, 70:1060-1070.
39. Boustière C., Veitch A., Vanbiervliet G., et al. Endoscopy and antiplatelet agents: European Society of Gastrointestinal Endoscopy (ESGE) guideline. Endoscopy 2011, 43:445-461.
40. Yasuda I., Tomita E., Enya M., et al. Can endoscopic papillary balloon dilation really preserve sphincter of Oddi function?. Gut 2001, 49:686-691.
41. Freeman M.L. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 2007, 5:1354-1365.
42. Aizawa T., Ueno N. Stent placement in the pancreatic duct prevents pancreatitis after endoscopic sphincter dilation for removal of bile duct stones. Gastrointest Endosc 2001, 54:209-213.
43. Freeman M.L., Overby C., Qi D. Pancreatic stent insertion: consequences of failure and results of a modified technique to maximize success. Gastrointest Endosc 2004, 59:8-14.
44. Smithline A., Silverman W., Rogers D., et al. Effect of prophylactic main pancreatic duct stenting on the incidence of biliary endoscopic sphincterotomy-induced pancreatitis in high-risk patients. Gastrointest Endosc 1993, 39:652-657.
45. Ochi Y., Mukawa K., Kiyosawa K., et al. Comparing the treatment outcomes of endoscopic papillary dilation and endoscopic sphincterotomy for removal of bile duct stones. J Gastroenterol Hepatol 1999, 14:90-96.
46. Arnold J.C., Benz C., Martin W.R., et al. Endoscopic papillary balloon dilation vs sphincterotomy for removal of common bile duct stones: a prospective randomized pilot study. Endoscopy 2001, 33:563-567.
47. Natsui M., Narisawa R., Motoyama H., et al. What is an appropriate indication for endoscopic papillary balloon dilation?. Eur J Gastroenterol Hepatol 2002, 14:635-640.
48. Tanaka S., Sawayama T., Yoshioka T. Endoscopic papillary balloon dilation and endoscopic sphincterotomy for bile duct stones: long-term outcomes in a prospective randomized controlled trial. Gastrointest Endosc 2004, 59:614-618.